Companies / enGene Therapeutics Inc. / Activity
Activity — enGene Therapeutics Inc.
1 move.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Cooper Ronald Harold Wilfred CEO | Grant | Stock Option (Right to Buy) | — | +801K | 801,000 1.20% of shares | low |